Big pharmas and biotechs alike need to consider the impact of reimbursement on a product's market opportunity when structuring deals, given the growing influence of payers, but industry execs grappled with how to do this at the BIO-Windhover Pharmaceutical Strategic Outlook conference in New York City on Feb. 24.
Continue reading "Coming In Monday's "The Pink Sheet" DAILY - News From The BIO-Windhover Pharmaceutical Strategic Outlook Conference" »
President Obama meets with administration officials and Democrat and Republican leaders of the House and Senate during the anticiapted bipartisan health care reform summit, where both sides will try and find some common ground to move legislation forward.
Continue reading "Coming in Friday's "The Pink Sheet" DAILY - President Obama Meets with Congressional Leaders to push forward health care reform bill" »
Anthera Pharmaceuticals has postponed an initial public offering through which it hoped to raise $64 million by selling 4.6 million shares of stock in the $13-$15 price range.
Continue reading "Coming in Thursday's "The Pink Sheet" DAILY - Anthera Pharmaceutials Postpones IPO" »